Business Models

Our Service

We develop our business while keeping as a central theme the area of Unmet Medical Needs of intractable peptic ulcer disease, as well as highly marketable antibody-inducing peptides.

In areas of intractable ulcer treatment drugs such as decubitus ulcers, where, even today, the treatment satisfaction rate for both doctors and patients is low, and antibody-inducing peptides are expected to reduce the economic burden of patients as well as the burden of medical finances, and be the innovation that will replace high-priced antibody drugs.

Furthermore, integrating the development of functional cosmetic products and medical devices, etc., that enable us to commercialize with relatively a short time and has a low development-associated risk compared to pharmaceutical drugs, as another pillar of our business in addition to our partnership with each manufacturer, we develop a business that also brings our own company’s sales in perspective.

Thus, as a corporation that contributes to society in the broad area of improvement of the QOL (Quality Of Life) of not only patients who suffer from diseases but also healthy individuals who hope to remain healthy, we aim through incorporating a number of business areas and building a solid business foundation, to be a stable company in the midst of fiercely competing drug development business.

Relate contents